ATF |
activating transcription factor |
BET |
bromodomain and extra C-terminal |
Bim1 |
a BH3 domain-containing pro-apoptotic protein |
CDK |
cyclin-dependent kinase |
CHOP |
CAAT/enhancer binding protein homologous protein |
eIF2 |
eukaryotic translation initiation factor |
ER |
estrogen receptor |
ERK1/2 |
extracellular signal-regulated kinase 1/2 |
HER2 |
human epidermal growth factor receptor 2 |
HIF-1 |
hypoxia-inducible factor-1 |
HLA |
human leukocyte antigen |
HTLV-1 |
human T-lymphotropic virus type 1 |
IFN-g |
interferon gamma |
LAG3 |
lymphocyte activation gene-3 |
MAPK |
mitogen-activated protein kinase |
MDSC |
myeloid-derived suppressor cells |
MHC |
major histocompatibility |
MMP |
matrix metalloproteinase |
mTOR |
mammalian target of rapamycin |
NF-kB |
nuclear factor-kappa B |
NLR |
neutrophil-to-lymphocyte ratio |
PARP |
poly ADP-ribose polymerase |
PDX |
patient-derived xenograft |
PI3K |
phosphatidyl inositol 3 kinase |
PTEN |
phosphatase and tensin homolog |
PR |
progesterone receptor |
ROS |
reactive oxygen species |
STAT |
signal transducers protein kinase |
TIM-3 |
T-cell immunoglobulin domain and Mucin domain 3 |
TIMP-1 |
tissue inhibitor of metalloproteinase-1 |
TNBC |
triple-negative breast cancer |
TRAIL |
tumor necrosis factor-related apoptosis-inducing ligand |
Treg |
T-regulatory cell |
UPR |
unfolded protein response |
VEGF |
vascular endothelial growth factor. |